EP3253412
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEASES OR DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.2.2016EP published:
23.3.2022EP application number:
16747111.9
EPO information:
European Patent Register
Max expiry date:
1.2.2036
Title in English:
ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEASES OR DISORDERSLanguage of the patent:
English
Timeline
Today
2.2.2016EP application
23.3.2022EP Publication
Owner
Name:
ALS Therapy Development InstituteAddress:
300 Technology Square Suite 400, Cambridge, Massachusetts 02139, US
Inventor
Name:
LINCECUM, John, M.Address:
Jamaica Plain, MA 02130, US
Name:
JIANG, BingbingAddress:
Brighton, MA 02135, US
Name:
PERRIN, Steven, N.Address:
Newbury, MA 01951, US
Name:
GILL, AlanAddress:
Reading, MA 01867-3959, US
Name:
GILL, Cynthia, A.Address:
Reading, MA 01867-3959, US
Name:
VIEIRA, Fernando G.Address:
Boston, MA 02114, US
Priority
Number:
201562111261 PDate:
3.2.2015Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 21/00, A61P 21/04, A61P 25/00, A61P 25/16, A61P 25/28, A61P 29/00, A61P 37/02